Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Anat

Anat Achiron, Tel-Aviv IL

Patent application numberDescriptionPublished
20100074864METHODS AND KITS FOR PREDICTING PROGNOSIS OF MULTIPLE SCLEROSIS - Provided are methods and kits for predicting the prognosis of a subject diagnosed with multiple sclerosis by determining the expression level of polynucleotides which are differentially expressed between subjects diagnosed with multiple sclerosis and having good or poor clinical outcome. Also provided are methods and kits for selecting a treatment regimen of a subject diagnosed with multiple sclerosis.03-25-2010
20100112568METHODS AND KITS FOR DIAGNOSIS OF MULTIPLE SCLEROSIS IN PROBABLE MULTIPLE SCLEROSIS SUBJECTS - Provided are methods and kits for determining the probability of a subject diagnosed with probable multiple sclerosis to develop definite diagnosis of multiple sclerosis by determining the expression level of polynucleotides which are differentially expressed between subjects diagnosed with probable multiple sclerosis and which further develop definite multiple sclerosis and unaffected subjects. Also provided are methods and kits for selecting a treatment regimen of a subject diagnosed with probable multiple sclerosis.05-06-2010
20100150868Methods of Individually Optimizing Treatment for an Inflammation Associated Disease - A method of individually optimizing a treatment for an inflammation associated disease is provided. The method comprising contacting each of identical white blood cell samples of a subject in need thereof with a different pharmaceutical agent of a plurality of pharmaceutical agents for the inflammation associated disease, so as to allow elicitation of an anti-inflammatory activity in the white blood cell samples; assaying the anti-inflammatory activity in the white blood cell samples; and identifying a pharmaceutical agent of the plurality of pharmaceutical agents eliciting a strongest anti-inflammatory activity, the pharmaceutical agent being the individually optimized treatment for the inflammation associated disease, wherein when the inflammation associated disease is multiple sclerosis the white blood cell samples are inflamed white blood cell samples. Methods of treating an inflammation associated disease are also described.06-17-2010
20120020954METHODS OF PREDICTING CLINICAL COURSE AND TREATING MULTIPLE SCLEROSIS - Provided are methods and kits for classifying a subject as being more likely to have benign multiple sclerosis (BMS) or as being more likely to have typical relapsing remitting multiple sclerosis (RRMS). Classification of multiple sclerosis disease course is performed by comparing a level of expression of at least one gene involved in the RNA polymerase I pathway in a cell of the subject to a reference expression data of said at least one gene obtained from a cell of at least one subject pre-diagnosed as having BMS and/or from a cell of at least one subject pre-diagnosed as having typical RRMS, thereby classifying the subject as being more likely to have BMS or as being more likely to have typical RRMS. Also provided are methods of diagnosing and treating multiple sclerosis and methods of monitoring treatment efficiency.01-26-2012

Patent applications by Anat Achiron, Tel-Aviv IL

Anat Bar-Anan, Tel Aviv IL

Patent application numberDescriptionPublished
20100217890USING SERVER TYPE TO OBTAIN NETWORK ADDRESS - Aspects of the subject matter described herein relate to using server type to obtain a network address. In aspects, a gateway that sits between a single network protocol client and a server receives a request from the client for a network address of the server. The gateway issues multiple name resolution requests and waits for a first response. Depending on various factors, the gateway determines whether or not to wait for additional responses before responding to the client. If needed, the gateway may obtain an address of a translating device to assist the client in communicating with the server.08-26-2010
20110283103ONE TIME PASSWORDS WITH IPSEC AND IKE VERSION 1 AUTHENTICATION - A system adapted to condition access to a network over an IPsec session to clients providing a proper one-time-password, even though the network access control uses IKEv1, which does not support one-time-passwords. An authentication service receives from a client an access request including the one-time-password, and provides the one-time-password to a service that checks the password. The one-time-password service returns a cookie when the password is successfully validated and the client is properly authenticated. The cookie is passed on to the client computer, which uses the cookie as part of a request for a certificate. A certificate authority generates a certificate if a request for a certificate is received from an authenticated client, which in turn may be used to form the IPsec session for access to the network.11-17-2011

Anat Bashan, Nes Ziona IL

Patent application numberDescriptionPublished
20090081697Methods of growing crystals of free and antibiotic complexed large ribosomal subunits, and methods of rationally designing or identifying antibiotics using structure coordinate data derived from such crystals - Methods of growing crystals of free and antibiotic complexed large ribosomal subunits, coordinates defining the 3D atomic structure thereof and methods of utilizing such coordinates for rational design or identification of antibiotics or large ribosomal subunits having desired characteristics are disclosed.03-26-2009

Anat Ben-Shlomo, Beverly Hills, CA US

Patent application numberDescriptionPublished
20080253641Method for Drug Screening and Characterization by Calcium Flux - The instrumentation and methods described herein are based on imaging and measuring single cell dose response by fluorescent ion imaging that records live cell responses to drug doses with no apparent damage to the cells or toxic side effects. Dose response curves and other pharmacological parameters can be computed by imaging and measuring oscillation changes for each dose and each cell. Large variability of cellular responses under the same experimental conditions indicates that pharmacological benchmarks are determined by statistical distribution of cells and cellular physiology. The instrumentation and methods described herein provide a means of measuring statistical variability of cell populations for improved screening and development methods for drugs.10-16-2008

Anat Biegon, Port Jefferson, NY US

Patent application numberDescriptionPublished
20100209344Radio-methyl Vorozole and Methods for Making and Using the Same - Radiotracer vorozole compounds for in vivo and in vitro assaying, studying and imaging cytochrome P450 aromatase enzymes in humans, animals, and tissues and methods for making and using the same are provided. [N-radio-methyl] vorozole substantially separated from an N-3 radio-methyl isomer of vorozole is provided. Separation is accomplished through use of chromatography resins providing multiple mechanisms of selectivity.08-19-2010

Anat Bremler-Barr, Ramat Hasharon IL

Patent application numberDescriptionPublished
20100250737DETECTING AND CONTROLLING PEER-TO-PEER TRAFFIC - A method for communication management includes detecting addresses of peer nodes (09-30-2010
20110167030STATE MACHINE COMPRESSION FOR SCALABLE PATTERN MATCHING - A method for processing data includes encoding a finite automaton, which includes states and transitions between the states that express a plurality of predefined patterns, by grouping the states of the automaton into sets according to a common property shared by the states in each set, and assigning codes to the states according to the grouping. The codes are stored in an electronic memory, along with rules that are associated with the patterns. The automaton is traversed in order to identify one or more of the patterns in an input sequence of data elements by iteratively reading out the codes from the memory responsively to the data elements and to the codes that have been previously read out. Upon identifying a given pattern in the input sequence, an associated action is performed.07-07-2011
20110185077MULTI-PATTERN MATCHING IN COMPRESSED COMMUNICATION TRAFFIC - A method for processing data includes accepting a specification of a plurality of patterns, each pattern defining a respective uncompressed sequence of symbols. Multi-pattern matching is applied to an incoming stream of compressed communication traffic containing compression metadata so as to identify the patterns occurring in the stream while using the compression metadata to skip over parts of the stream.07-28-2011

Anat Bruchim, Jerusalem IL

Patent application numberDescriptionPublished
20100151020DRUG DELIVERY SYSTEM FOR ZERO ORDER, ZERO ORDER BIPHASIC, ASCENDING OR DESCENDING DRUG DELIVERY OF METHYLPHENIDATE - The invention is directed to a drug delivery device for controlled release of a drug, such as methylphenidate hydrochloride. The drug deliver device has a drug core, having a plug embedded therein, and at least a first coating that at least partially surrounds the core. The plug may be hollow or solid, and swells upon absorption of water, bursting through the first coating. The drag delivery device enables zero-order drug release profiles as well as more complicated release profiles to be obtained.06-17-2010

Anat Bzoza, Tel-Aviv IL

Patent application numberDescriptionPublished
20100328422Method and System for Composing Video Images from a Plurality of Endpoints - The present application discloses a method and apparatus for a multipoint video conferencing system that can offer a wide variety of layouts and the ability to support a large number of conferees. A received stream of NALs from a plurality of endpoints can be processed by an exemplary NAL Processor Module (NPM) and be arranged into a stream of NALs that are referred to in this disclosure as organized NALs (ONALs). Two or more streams of compressed video organized into ONALs can be received by an exemplary NAL Editor Module (NEM), wherein each stream was created from a video image that was generated at an endpoint participating in the conference. An exemplary NEM can comprise a compressed composed frame memory (CCFM) module. Each CCFM can be divided into segments according to the layout of the continuous presence (CP) image that is to be displayed by one or more receiving endpoints.12-30-2010

Anat Cohen-Dayag, Rehovot IL

Patent application numberDescriptionPublished
20090202991NOVEL DIAGNOSTIC MARKERS, ESPECIALLY FOR IN VIVO IMAGING AND ASSAYS AND METHODS OF USE THEREOF - Novel splice variants as diagnostic markers, preferably membrane-bound. The novel variants according to the present invention may optionally be used for diagnosis of Marker-detectable disease as described herein, optionally through immunohistochemistry.08-13-2009
20100189652NOVEL DIAGNOSTIC MARKERS, ESPECIALLY FOR IN VIVO IMAGING, AND ASSAYS AND METHODS OF USE THEREOF - Novel splice variants as diagnostic markers, preferably membrane-bound. The novel variants according to the present invention may optionally be used for diagnosis of Marker-detectable disease as described herein, optionally through immunohistochemistry.07-29-2010
20110003708BIOMARKERS FOR THE PREDICTION OF RENAL INJURY - The present invention relates to means and methods for predicting the onset of renal injury based on measuring the expression of polynucleotides and proteins, particularly on measuring the expression of sets of novel as well as known polynucleotides and proteins, and to kits utilizing same.01-06-2011
20110052501POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS - This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against KIAA0746, CD20 or CD55 antigens, which are differentially expressed in cancer and in specific blood cells, and diagnostic and therapeutic usages. This invention further relates to the discovery of extracellular domains of KIAA0746 and its variants, CD20 and its variants, CD55 and its variants, which are suitable targets for immunotherapy, cancer therapy, treatment of inflammatory, allergic and autoimmune disorders, and drug development.03-03-2011
20110311450POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS - This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against KRTCAP3, FAM26F, MGC52498, FAM70A or TMEM154 antigens, which are differentially expressed in cancer, and diagnostic and therapeutic usages. This invention further relates to extracellular domains of KRTCAP3, FAM26F, MGC52498, FAM70A and TMEM154 proteins and variants, and therapeutic usages thereof.12-22-2011

Patent applications by Anat Cohen-Dayag, Rehovot IL

Anat Fischer, Haifa IL

Patent application numberDescriptionPublished
20110022174MODELING MICRO-SCAFFOLD-BASED IMPLANTS FOR BONE TISSUE ENGINEERING - A new conceptual biomedical method is presented for designing scaffold-based bone implants and using these implants in treating deteriorated bones. These implants have micro-architectural bone structures that are capable of mimicking the stochastic micro-structure as in natural bone bio-mineral structures. Moreover, they can be adapted as specific tailor-made compatible bone-repair mediator implants to be used as effective substitutes for natural damaged bone fracture structures.01-27-2011

Anat Fradin, Rehovot IL

Patent application numberDescriptionPublished
20110161518ASYNCHRONOUS INVOCATION MECHANISM IN SESSION INITIATION PROTOCOL (SIP) SERVER CLUSTERS - Providing SIP application server interoperability, including detecting at a first SIP application server an event necessitating that work be performed in relation to a SIP application session that is managed by a second SIP application server, creating a SIP message object carrying a set of instructions representing the work, and sending the SIP message object for delivery to the second SIP application server and performance of the instructions at the second SIP application server in relation to the SIP application session.06-30-2011

Anat Frydman-Marom, Tel Aviv IL

Patent application numberDescriptionPublished
20110200692USE OF A CINNAMON BARK EXTRACT FOR TREATING AMYLOID-ASSOCIATED DISEASES - The present application disclosed the use of a cinnamon extract in the treatment of amyloid-associated diseases and disorders, such as Alzheimer's disease.08-18-2011

Anat Kaphan, Halonim IL

Patent application numberDescriptionPublished
20080234787Laser treatment procedure atlas - A user interface for a general purpose laser treatment system is provided. Generally, the user interface may be associated with a carbon dioxide (CO2) laser for use in various surgical procedures, for example, veterinary or medical surgical procedures. A treatment atlas including a collection of treatment procedures is stored within a database structure. The treatment procedures includes laser settings associated with each of the treatment procedures. The interface can provide a recommended treatment procedures to a user based on required application. The treatment atlas can be accessed through the internet and requested treatment procedures (and the corresponding laser settings) can be downloaded to a laser treatment system. The treatment atlas can also be a component of a Web 2.0 social networking system to enable users and system administrators to update and modify the collection of treatment procedures.09-25-2008

Anat Kerem-Angel, Tel-Aviv IL

Patent application numberDescriptionPublished
20110092892Body passage cleansing device - The present invention provides a body passage cleansing device suitable for being passed through an internal channel of an endoscope, comprising a distal plug having a proximal end and a distal end, wherein said plug comprises channels, apertures and/or nozzles which are capable of allowing the passage of a fluid therethrough from said proximal end to said distal end, wherein said plug is connected to the distal end of a wire or other actuating means; wherein at least an outer portion of said distal plug is capable of being elastically deformed such that the external diameter and/or outline thereof may be reduced in response to inwardly-directed compression forces exerted thereon; and wherein said channels, apertures and/or nozzles are in a closed conformation when said distal plug is subject to said compression forces, and in an open conformation when said plug is not subject to said compression forces.04-21-2011

Anat Lavi-Itzkovitz, Ramat-Gan IL

Anat Levi Segal, Shelomi IL

Patent application numberDescriptionPublished
20090144320METHOD FOR GENERATING AND USING A REUSABLE CUSTOM-DEFINED NESTABLE COMPOUND DATA TYPE AS DATABASE QUALIFIERS - A method for generating and using a reusable custom-defined nestable compound data type for use as a database qualifier provides significant advantages over using traditional non-reusable structured tables of RDBM systems is described. The method and data structures of the invention may be used to define and instantiate flexible nested-record structures that reverse and better expose the relationship between parent records and private child sub-records in a database schema to provide improved referential integrity and visibility into database structure.06-04-2009
20100131565Method for creating a self-configuring database system using a reusable custom-defined nestable compound data type - A method for creating a self-configuring database system using a reusable custom-defined nestable compound data type of the invention provides significant advantages over using traditional non-reusable structured tables of RDBM systems. A data structure concept and associated method support creating a self-configuring database system programmatically responsive to importing data using schema descriptions in multiple formats. Thus, the method and data structures of the invention may be used to define and instantiate flexible nested record structures that reverses and better exposes the relationship between parent records and private child sub-records in a database schema.05-27-2010

Anat Marchelli, Migdal Haemek IL

Patent application numberDescriptionPublished
20080286885METHODS AND SYSTEMS FOR CREATING OR PERFORMING A DYNAMIC SAMPLING SCHEME FOR A PROCESS DURING WHICH MEASUREMENTS ARE PERFORMED ON WAFERS - Various methods and systems for creating or performing a dynamic sampling scheme for a process during which measurements are performed on wafers are provided. One method for creating a dynamic sampling scheme for a process during which measurements are performed on wafers includes performing the measurements on all of the wafers in at least one lot at all measurement spots on the wafers. The method also includes determining an optimal sampling scheme, an enhanced sampling scheme, a reduced sampling scheme, and thresholds for the dynamic sampling scheme for the process based on results of the measurements. The thresholds correspond to values of the measurements at which the optimal sampling scheme, the enhanced sampling scheme, and the reduced sampling scheme are to be used for the process.11-20-2008

Anat Mirelman, Ramat-Gan IL

Patent application numberDescriptionPublished
20120109025MULTIPLE DEGREE OF FREEDOM REHABILITATION SYSTEM HAVING A SMART FLUID-BASED, MULTI-MODE ACTUATOR - A rehabilitation system that combines robotics and interactive gaming to facilitate performance of task-specific, repetitive, upper extremity/hand motor tasks, to enable individuals undergoing rehabilitation to improve the performance of coordinated movements of the forearm and hand is disclosed. More specifically, the rehabilitation system includes a two degree-of-freedom (DOF) robotic, upper limb rehabilitation system and interactive gaming hardware that is coupled to a computer, to provide a virtual reality-like environment.05-03-2012

Anat Ohali, Ramat Gan IL

Anat Perets, Narbeth, PA US

Patent application numberDescriptionPublished
20080213389Three-Dimensional Scaffolds for Tissue Engineering Made by Processing Complex Extracts of Natural Extracellular Matrices - Methods of making a biologically active three-dimensional scaffold capable of supporting growth and differentiation of a cell are described. Biologically active three-dimensional scaffold made by the methods of the invention and an engineered tissue made from the scaffolds are described. Fibers of desired porosity can be obtained from non-structural ECM by lyophilization and/or electrospinning which can be useful for numerous tissue engineering applications requiring complex scaffolds, such as wound healing, artificial skin (burns), soft tissue replacement/repair and spinal cord injury.09-04-2008

Anat Shiloach, Trumbull, CT US

Patent application numberDescriptionPublished
20110118162LIQUID PERSONAL CLEANSING COMPOSITION - A mild, substantially isotropic skin cleansing solution was found to be able to suspend insoluble components and provide copious amounts of lather. The cleanser is formulated with synthetic anionic surfactants and a specific ratio of carboxylic acid(s) to hydrophobically modified cross-linked acrylate copolymer(s). The carboxylic acid and acrylate polymer combination were found to provide a synergistic effect on zero shear viscosity at 25 C in a specific pH and copolymer/acid concentration ratio range.05-19-2011

Anat Shirvan, Herzliya IL

Patent application numberDescriptionPublished
20080279774Perturbed Membrane-Binding Compounds And Methods Of Using The Same - The present invention relates to compounds that selectively bind to cells undergoing perturbations and alterations of their normal plasma membrane organization, such as cells undergoing apoptosis or activated platelets. The invention further provides methods for utilizing said compounds in medical practice, for diagnostic and therapeutic purposes.11-13-2008
20100035296COMPOUNDS AND METHODS FOR DETECTION OF CELLS - The invention relates to compounds comprising an ester group for the detection in vivo of cells undergoing cell death (“dying cells”) such as, for example, cells undergoing apoptosis. These compounds are selectively retained in dying cells relative to normal cells. Thus, the compounds may be used in the detection, diagnosis and treatment of clinical conditions manifested by a cell death process.02-11-2010
20110257434PERTURBED MEMBRANE-BINDING COMPOUNDS AND METHODS OF USING THE SAME - The invention relates to compounds that selectively bind to cells undergoing perturbations and alterations of their normal plasma membrane organization, i.e., cells undergoing cell death, apoptotic cells or activated platelets. The invention further provides methods for utilizing the compounds in medical practice, for diagnostic and therapeutic purposes.10-20-2011

Patent applications by Anat Shirvan, Herzliya IL

Anat Sneh, Boulder, CO US

Patent application numberDescriptionPublished
20110310526CAPACITORS WITH HIGH ENERGY STORAGE DENSITY AND LOW ESR - Electrostatic capacitors with high capacitance density and high-energy storage are implemented over conventional electrolytic capacitor anode substrates using highly conformal contact layers deposited by atomic layer deposition. Capacitor films that are suitable for energy storage, electrical and electronics circuits, and for integration onto PC boards endure long lifetime and high-temperature operation range.12-22-2011

Anat Sofer-Raz, Herot IL

Patent application numberDescriptionPublished
20090088424METHODS AND COMPOSITIONS FOR CONTROLLING THE BIOAVAILABILITY OF POORLY SOLUBLE DRUGS - Provided are methods and compositions for controlling the bioavailability of poorly soluble drugs, including, for example, efravirenz.04-02-2009

Anat Thieberger Ben-Haim, Kiryat Tivon IL

Patent application numberDescriptionPublished
20100159426LANGUAGE SKILLS FOR INFANTS - Methods and devices for stimulating the development of phonetic categories by an infant. The device includes a memory element operative to store auditory pieces comprising isolated phonemes in a voice similar to the voice of the infant's parent. The method includes the steps of recording the infant's parent pronouncing isolated phonemes, and playing to the infant auditory pieces comprising isolated phonemes based on the recordings of the infant's parent.06-24-2010

Anat Thieberger Ben-Haom, Kiryat Tivon IL

Patent application numberDescriptionPublished
20090226861Language skill development according to infant development - Methods and devices for stimulating an infant to develop additional phonetic categories, including: estimating the infant's development; and selecting an auditory piece appropriate to the estimated development. Wherein the auditory piece comprises isolated phonemes in the infant's parent's voice.09-10-2009

Anat Zvi, Gedera IL

Patent application numberDescriptionPublished
20090136534NOVEL RECOMBINANT BCG TUBERCULOSIS VACCINE DESIGNED TO ELICIT IMMUNE RESPONSES TO MYCOBACTERIUM TUBERCULOSIS IN ALL PHYSIOLOGICAL STAGES OF INFECTION AND DISEASE - A vaccine against 05-28-2009
20110117133Novel Recombinant BCG Tuberculosis Vaccine Designed to Elicit Immune Responses to Mycobacterium Tuberculosis in all Physiological Stages of Infection and Disease - A vaccine against 05-19-2011
20110206714MALARIA VACCINE COMPOSITIONS AND CONSTITUENTS WHICH ELICIT CELL MEDIATED IMMUNITY - Malaria vaccines based on polyepitope constructs that elicit cell-mediated immunity against a broad spectrum of malaria parasites and which cover the majority of HLA alleles are provided. Epitopes in the polyepitope constructs are from regions of the 08-25-2011